Noninvasive estimation of serum bilirubin

Area of Science:

• Neonatal Medicine
• Medical Devices
• Diagnostic Technology

Background:

• Neonatal jaundice is common and requires monitoring of serum bilirubin levels.
• Current methods for bilirubin measurement often involve invasive blood draws.
• Accurate, non-invasive methods are needed to improve infant care and reduce healthcare burdens.

Purpose of the Study:

• To evaluate the accuracy and clinical utility of the Chromatics Colormate III, a novel computer-driven device for estimating neonatal serum bilirubin via skin reflectance.
• To determine if the device provides reliable measurements across diverse infant populations and conditions.

Main Methods:

• A total of 2441 neonates (term and premature) underwent transcutaneous bilirubin measurements using the Chromatics Colormate III.
• 900 infants had concurrent laboratory serum bilirubin determinations for comparison.
• Reproducibility was assessed using standardized tiles and multiple operators; phototherapy effects were also studied.

Main Results:

• A strong correlation (r=0.956) was observed between device estimates and serum bilirubin levels.
• 95% of skin color measurements fell within 32.2 micromol/L (2.0 mg/dL) of serum bilirubin.
• The device demonstrated accuracy irrespective of infant race or weight, and was unaffected by phototherapy. Reproducibility was high (CV 3.1%).

Conclusions:

• The Chromatics Colormate III provides a clinically useful, non-invasive estimate of serum bilirubin in neonates.
• This device can potentially reduce the need for invasive blood tests, enabling safer early discharge and decreased healthcare costs.
• Its application in newborn nurseries offers significant advantages for routine infant jaundice screening.